首页> 外国专利> APOLIPOPROTEIN A-1 MIMIC PEPTIDES, AND THERAPEUTIC AGENT FOR TREATING HYPERLIPIDEMIA AND DISEASES RELATED TO HYPERLIPIDEMIA COMPRISING SAME

APOLIPOPROTEIN A-1 MIMIC PEPTIDES, AND THERAPEUTIC AGENT FOR TREATING HYPERLIPIDEMIA AND DISEASES RELATED TO HYPERLIPIDEMIA COMPRISING SAME

机译:载脂蛋白A-1模拟肽和治疗血脂过多和与血脂过多有关的疾病的治疗剂

摘要

The present invention relates to apolipoprotein A-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising the same. More specifically, the apolipoprotein A-1 mimic peptides of the present invention were manufactured by modifying hydrophilic or hydrophobic face of existing 4F amphipathic peptides to produce Apo A-I mimic peptides which specifically bind with cholesterol ester to allow high density lipoprotein content to increase, and the peptide of which phenylalanine in hydrophobic face of 4F is substituted with 2-naphthylalanine has superior cholesterol efflux capability and cognitive function for lipids to the existing 4F peptides, among the mimic peptides. Thus, the Apo A-I mimic peptides of the present invention can be used as Apo A-I mimic peptides and as a therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia.
机译:本发明涉及载脂蛋白A-1模拟肽,以及用于治疗高脂血症和与高脂血症有关的疾病的治疗剂。更具体地,本发明的载脂蛋白A-1模拟肽是通过修饰现有的4F两亲性肽的亲水或疏水表面以产生与胆固醇酯特异性结合以允许高密度脂蛋白含量增加的Apo AI模拟肽来制造的,并且在模拟肽中,其中4F疏水面上的苯丙氨酸被2-萘丙氨酸取代的肽具有优于现有4F肽的胆固醇外排能力和对脂质的认知功能。因此,本发明的Apo A-1模拟肽可以用作Apo A-1模拟肽,并且可以用作治疗高脂血症和与高脂血症有关的疾病的治疗剂。

著录项

  • 公开/公告号US2012270771A1

    专利类型

  • 公开/公告日2012-10-25

    原文格式PDF

  • 申请/专利权人 JAEHOON YU;

    申请/专利号US200913499357

  • 发明设计人 JAEHOON YU;

    申请日2009-09-30

  • 分类号C40B40/10;A61P9/10;A61P9;C40B30/06;A61P25/28;A61P25;A61P3/04;A61P3/06;A61K38/10;A61P3/10;

  • 国家 US

  • 入库时间 2022-08-21 17:34:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号